Shanghai Rightongene Biotechnology Co., Ltd. (SHA:688217)
China
· Delayed Price · Currency is CNY 29.55
-0.62 (-2.06%)
At close: Mar 9, 2026
SHA:688217 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2018 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2018 |
| Net Income | - | -15.76 | 7.93 | 40.47 | 47.33 | Upgrade
|
| Depreciation & Amortization | - | 43.39 | 44.4 | 35.73 | 37.52 | Upgrade
|
| Other Amortization | - | 3.27 | 1.18 | 2.77 | 4.06 | Upgrade
|
| Loss (Gain) From Sale of Assets | - | -0.12 | -0.84 | 0.01 | 0.1 | Upgrade
|
| Asset Writedown & Restructuring Costs | - | 16.67 | 7.64 | 14.16 | -1.5 | Upgrade
|
| Loss (Gain) From Sale of Investments | - | -2.49 | -3.01 | -3.1 | -1.47 | Upgrade
|
| Provision & Write-off of Bad Debts | - | 6.65 | 5.03 | 9.56 | 1.06 | Upgrade
|
| Other Operating Activities | - | -8.6 | -10.87 | 21.64 | -5.28 | Upgrade
|
| Change in Accounts Receivable | - | 14.49 | 182.51 | -101.21 | 2.87 | Upgrade
|
| Change in Inventory | - | 9.79 | -15.93 | -16.97 | -10.8 | Upgrade
|
| Change in Accounts Payable | - | 2.86 | -167.29 | 64.84 | 3.62 | Upgrade
|
| Change in Other Net Operating Assets | - | -4.1 | 2.15 | 8.84 | - | Upgrade
|
| Operating Cash Flow | - | 59.98 | 45.1 | 73.07 | 77.97 | Upgrade
|
| Operating Cash Flow Growth | - | 33.00% | -38.28% | -6.28% | 11.20% | Upgrade
|
| Capital Expenditures | - | -39.41 | -109.09 | -106.57 | -95.6 | Upgrade
|
| Sale of Property, Plant & Equipment | - | 0.14 | 0.22 | - | 1.39 | Upgrade
|
| Investment in Securities | - | -21.98 | 3.56 | 109.03 | -188.56 | Upgrade
|
| Other Investing Activities | - | 1.99 | 2.74 | 4.58 | 4.19 | Upgrade
|
| Investing Cash Flow | - | -59.27 | -102.58 | 7.04 | -278.57 | Upgrade
|
| Long-Term Debt Issued | - | - | 20 | 1.35 | - | Upgrade
|
| Total Debt Issued | - | - | 20 | 1.35 | - | Upgrade
|
| Long-Term Debt Repaid | - | -23.08 | -7.22 | -5.87 | -4.62 | Upgrade
|
| Total Debt Repaid | - | -23.08 | -7.22 | -5.87 | -4.62 | Upgrade
|
| Net Debt Issued (Repaid) | - | -23.08 | 12.78 | -4.52 | -4.62 | Upgrade
|
| Issuance of Common Stock | - | - | 8.97 | - | 224.04 | Upgrade
|
| Common Dividends Paid | - | -0.62 | -10.4 | -0.01 | -0.02 | Upgrade
|
| Other Financing Activities | - | - | - | - | -27.59 | Upgrade
|
| Financing Cash Flow | - | -23.7 | 11.36 | -4.53 | 191.8 | Upgrade
|
| Foreign Exchange Rate Adjustments | - | 0.66 | 0.84 | 4.69 | -1.54 | Upgrade
|
| Net Cash Flow | - | -22.33 | -45.29 | 80.26 | -10.35 | Upgrade
|
| Free Cash Flow | - | 20.57 | -64 | -33.5 | -17.63 | Upgrade
|
| Free Cash Flow Margin | - | 8.49% | -24.79% | -7.90% | -6.06% | Upgrade
|
| Free Cash Flow Per Share | - | 0.36 | -1.13 | -0.60 | -0.35 | Upgrade
|
| Cash Income Tax Paid | - | 9.99 | 17.59 | 1.16 | -1.81 | Upgrade
|
| Levered Free Cash Flow | - | 25.32 | -63.29 | -58.2 | -31.58 | Upgrade
|
| Unlevered Free Cash Flow | - | 25.87 | -62.77 | -57.86 | -31.28 | Upgrade
|
| Change in Working Capital | - | 16.98 | -6.36 | -48.18 | -3.86 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.